are they stopping semaglutide A South African court has ordered pharmacy group iDexis to stop selling semaglutide-based medicines. The ruling follows a legal challenge by Novo Nordisk, maker of Ozempic and Wegovy. Novo alleged the company Hims & Hers stock falls

National Center for Health Statistics

5-Amino-1MQ is sold for laboratory, research, or analytical purposes only not for human consumption, veterinary use, or medical applications

doi:10.1093/asjof/ojag011 Articles in this issue about 1 month ago Dermatology Times June 2026 Print Recap about 1 month ago Dont Be Rash: Treating Kids Skin Isnt the Same about 1 month ago The Sun Bus Model: Screening, Education, and Research on Wheels about 2 months ago Preservatives: The Villain in the Bottle about 2 months ago The Expanding Role of Immunotherapies for Non-Melanoma Skin Cancers about 2 months ago Digital Twins in Dermatology: Your Patients Virtual Double Is Coming about 2 months ago Filling the HS Treatment Gap: Ruxolitinib Targets Early-Stage Disease

Rondanelli M, Perna S, Riva A, Petrangolini G, Di Paolo E, Gasparri C

Ozempic is usually administered once a week via subcutaneous injection